Psyence Biomedical (PBM) Total Current Liabilities (2022 - 2024)

Psyence Biomedical has reported Total Current Liabilities for 3 years, with the latest figure at $122077.6 in Q1 2024.

• On a quarterly basis, Total Current Liabilities fell 7.27% year-over-year to $122077.6 in Q1 2024; TTM through Mar 2024 was $122077.6, a 7.27% decrease from a year earlier, with the FY2024 full-year figure at $122077.6, down 7.27% from the prior year.
• Total Current Liabilities was $122077.6 for Q1 2024 at Psyence Biomedical, down from $28.7 million in the prior quarter.
• The five-year high for Total Current Liabilities was $28.7 million in Q3 2023, with the low at $122077.6 in Q1 2024.
• Average Total Current Liabilities over 3 years is $10.8 million, with a median of $7.2 million recorded in 2022.
• The largest YoY upside for Total Current Liabilities was 7.27% in 2024 against a maximum downside of 7.27% in 2024.
• Over 3 years, Total Current Liabilities stood at $14.3 million in 2022, then surged by 101.45% to $28.7 million in 2023, then slumped by 99.58% to $122077.6 in 2024.
• The last three Total Current Liabilities figures came in at $122077.6 (Q1 2024), $28.7 million (Q3 2023), and $131642.0 (Q1 2023), per Business Quant data.